IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro

Hahn, F; Wangen, C; Hage, S; Peter, AS; Dobler, G; Hurst, B; Julander, J; Fuchs, J; Ruzsics, Z; Uberla, K; Jack, HM; Ptak, R; Muehler, A; Groppel, M; Vitt, D; Peelen, E; Kohlhof, H; Marschall, M

Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Clin & Mol Virol, Schlossgarten 4, D-91054 Erlangen, Germany.

VIRUSES-BASEL, 2020; 12 (12):